9 unchanged sentences
The timing, amount and form of dividends, if any, will depend on, among other things, our results of operations, financial condition, cash requirements and other factors deemed relevant by our Board of Directors.
−Removed: The Series A Preferred Stock, none of which remains outstanding, ranked senior to the shares of our common stock and shares of our Series B Preferred Stock with respect to dividend rights and holders of Series A Preferred Stock were entitled to a cumulative dividend at the rate of 2.0% per annum, payable quarterly in arrears, as set forth in the Certificate of Designation of Series A Convertible Preferred Stock.
+Added: The Series A Preferred Stock, none of which remains outstanding, ranked senior to the shares of our common stock and shares of our Series B Preferred Stock with respect to dividend rights and holders of Series A Preferred Stock, none of which remains outstanding, were entitled to a cumulative dividend at the rate of 2.0% per annum, payable quarterly in arrears, as set forth in the Certificate of Designation of Series A Convertible Preferred Stock.
The Series C Preferred Stock and Series D Preferred Stock is entitled to receive dividends on an as-if-converted-to-common-Stock basis to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the common stock.
8 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: On December 22, 2022, we repurchased an aggregate of 720,000 shares of our common stock, par value $0.001 (the “Common Stock”) from three founders of its subsidiary Theriva Biologics S.L.
−Removed: (formerly known as VCN Biosciences S.L.) in a privately negotiated
−Removed: transaction pursuant to the terms of a Share Repurchase Agreement (the “Share Repurchase Agreement”) entered into on December 20, 2022 with each of the Selling Stockholders.
−Removed: Summary of the 2022 stock repurchase activity is as follows:
−Removed: Total number of
−Removed: shares purchased as
−Removed: Maximum number of
−Removed: part of publicly
−Removed: shares that may yet be
−Removed: Total number of
−Removed: Average price paid
−Removed: announced plans or
−Removed: purchased under the
−Removed: shares purchased
−Removed: plans or programs
−Removed: December 2022
+Added: We did not repurchase any equity securities during the fourth quarter or year ended December 31, 2023.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.